Validation of an inhouse developed therapeutic dosimetric software tool for the treatment of 177 LutetiumDOTATATE peptide receptor redionuclide therapy

B Van WykF HasfordN NYAKALEMboyo-Di-Tamba Vangu2024-11-262024-11-26SCOPUS21907188https://hdl.handle.net/10539/42914Validation of an inhouse developed therapeutic dosimetric software tool for the treatment of 177 LutetiumDOTATATE peptide receptor redionuclide therapyJournal Article